Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5695770 | Gynecologic Oncology | 2017 | 8 Pages |
Abstract
MiR-138 may be a tumor suppressor and potential prognostic biomarker in cervical cancer. Its downstream target, TCF3, may also regulate cancer development in a reverse manner as miR-138.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Huiqin Li, Yang Sheng, Ying Zhang, Nan Gao, Xiangyun Deng, Xiugui Sheng,